InvestorsHub Logo

1776club

05/04/21 3:04 PM

#9851 RE: Brandywhitneylady #9847

Abivertinib Maleate Brazil Study completes in May 2021
400 participants
Hospital e Maternidade Christovão da Gama
Santo André, SP, Brazil
COMPLETION DATE MAY 2021
The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "estimated" study completion date is the date that the researchers think will be the study completion date.
Would like to hear general results quickly. If successful then a big yes for India. Sorrento knows how things are going and if a positive outcome is the findings then they should be talking to INDIA.

COVI-MSC would be the best, or so it seems, but limited doses are only available as more capital This is from April 2020.
"After this initial FDA trial is started, PSC will apply to FDA for a wider compassionate use approval and could also ship cells internationally. PSC is already ramping its manufacturing but is constrained by capital for critical supplies used in making these cells. “With adequate capital (investors or philanthropy), we could manufacture stem cell treatments for up to 8,000 patients per month,” said Dr. Harman."
They have found a company to do just that and in January this year and on Mar 12, 2021 Performance Cell Manufacturing Announced an Expanded cGMP Cell Manufacturing Facility. Don't forget this is being pushed by the WH.